Company intelligence / Profile preview
S1 Biopharma
New York City, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
S1 Biopharma is a clinical-stage biotech company developing non-hormonal, oral drugs for sexual dysfunction in women and men, notably targeting HSDD and erectile dysfunction. Its most advanced candidate, Lorexys, is a fixed-dose combination of bupropion and trazodone, which acts on multiple brain neurotransmitter systems. The company uses rigorous clinical designs and has completed Phase 2 trials for its lead candidate; no FDA-approved drugs for HSDD exist yet, so S1 Biopharma is addressing a large unmet need[1][4][6].
- Therapeutic areas
- Men's HealthWomen's HealthPsychiatry
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Medical advisory board with academic and industry experts[1]Engaged US Capital Global Securities for capital raise[5]
Beyond the preview
Go deeper on S1 Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on S1 Biopharma.